About EBSA17 Conference - Ghent
EBSA17 Conference - Ghent
Scientific Programme
Thursday, 15th May 2014 |
|
08:30 |
Opening |
08:45 |
Welcome in Ghent |
08:50 |
Safety of GM crops: achievements and controversy |
09:30 |
Web-based information on biosafety: A 20-year success story with the Belgian Biosafety Server |
10:00 |
Coffee break + Poster I |
Crossing the border from contained use to deliberate release |
|
10:30 |
Malaria fear in Belgium and elsewhere in Europe: how much can we blame the global warming? M. Coosemans, Institute of Tropical Medicine, Antwerpen/B |
11:00 |
Containment of medical and veterinary pathogen vectors |
11:30 |
Deliberate release of genetically modified insects - experiences and challenges |
12:00 |
Public display of GMO containing materials in the Netherlands, a series of surprises |
12:30 |
Lunch |
Human infection studies |
|
13:30 |
Use of a human influenza challenge model for the study of modes of influenza transmission J. Van-Tham, University of Nottingham/UK |
14:00 |
A clinical trial using genetically-modified parasites; a novel vaccine against malaria S.M. Khan, Leiden Malaria Research Group, Leiden University Medical Center/NL; R. Sauerwein, Radboud University Medical Center, Nijmegen/NL;C.J. Janse, Leiden Malaria Research Group, Leiden University Medical Center/NL |
14:30 |
A multipurpose, multiuser containment level 3 laboratory - can it work? |
15:00 |
Coffee break + Poster II |
Bridging the borders between legislations |
|
15:30 |
Alkaline hydrolysis for animal carcass disposal: a regulatory challenge |
Chris Collins Lecture |
|
16:00 |
Biosafety and the global community - What's next? |
17:00 |
AGM - Annual General Meeting |
19:30 |
Conference Dinner at Oude Vismijn (end ca. 23:00) |
Friday, 16th May 2014 |
|
At the border of biosafety |
|
08:30 |
Biosecurity and dual use research - debate and policy in the Netherlands K. van der Bruggen, Royal Netherlands Academy of Arts and Sciences/NL |
09:00 |
When does a misfolded protein become toxic? |
09:30 |
Risk assessment challenges of synthetic biology |
10:00 |
Biosafety and legal considerations for organisms developed through new modification technologies |
10:30 |
Coffee break + Poster III |
11:00 |
Break-out discussion groups |
|
A. Discussion: |
Biocontainment of equipment |
|
B. Discussion: |
What do you need to know before sending material to a third party? |
C. Discussion: |
Working with plant quarantine organisms |
|
D. Discussion: |
Maternity protection against biological risks - approach and policy in Belgium |
|
E. Discussion: Moderators: |
Crossing borders between contained use and deliberate release: How contained use can deliberate release and vice-versa R. Custers, VIB, Ghent/B |
|
F. Toolbox: |
Cleaning up spills, donning and doffing of gloves and other PPE or how to stop your panic when it drips and splashes |
|
G. Discussion |
High containment labs versus cleanrooms: synergy and conflicts E. Kampert, National Institute of Public Health and the Environment, Bilthoven/NL K. Summermatter, Institute of Virology and Immunology, Mittelhäusern/CH |
12:30 |
Lunch |
Crossing the border from experiment to human infection (LAI) |
|
13:30 |
Laboratory-acquired infections in Belgium (2007-2012) - an online survey |
14:00 |
2008 laboratory-acquired Vaccinia infection: a retrospective |
14:30 |
Increase in TB cases in Georgia: possible link with medical waste management |
15:00 |
Infection of an animal care taker with Ecthyma contagiosum, a parapox virus |
15:30 |
Closing: |